Grants per year
Personal profile
Training Experience
| 2010 | Postdoctoral Fellowship, Northwestern University Feinberg School of Medicine |
Education/Academic qualification
PhD, University of Rostock
… → 1995
MD, University of Rostock
… → 1994
Fingerprint
Dive into the research topics where Jan Wysocki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Novel Short ACE2 variant for Delayed Graft Function
Batlle, D., Ansari, M. J. I., Wysocki, J. & Zhang, Z. J.
National Institute of Allergy and Infectious Diseases
11/1/21 → 10/31/23
Project: Research project
-
NCR-19-2039- Ammonium excretion in ZS-9 treated mice with CKD
AstraZeneca Pharmaceuticals LP
5/26/20 → 10/31/22
Project: Research project
-
Urinary Renin Angiotensin System in Diabetes
Batlle, D., Molitch, M. E., Rademaker, A. W. & Wysocki, J.
National Institute of Diabetes and Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
-
ACE2 as Therapeutic Target for Kidney Disease in Diabetic Mice
12/1/07 → 6/30/11
Project: Research project
-
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 Infection
Hassler, L., Wysocki, J., Gelarden, I., Sharma, I., Tomatsidou, A., Ye, M., Gula, H., Nicoleascu, V., Randall, G., Pshenychnyi, S., Khurram, N., Kanwar, Y., Missiakas, D., Henkin, J., Yeldandi, A. & Batlle, D., Jul 2022, In: Journal of the American Society of Nephrology. 33, 7Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
El-Shennawy, L., Hoffmann, A. D., Dashzeveg, N. K., McAndrews, K. M., Mehl, P. J., Cornish, D., Yu, Z., Tokars, V. L., Nicolaescu, V., Tomatsidou, A., Mao, C., Felicelli, C. J., Tsai, C. F., Ostiguin, C., Jia, Y., Li, L., Furlong, K., Wysocki, J., Luo, X., Ruivo, C. F., & 16 others, Dec 2022, In: Nature communications. 13, 1, 405.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
Batlle, D., Monteil, V., Garreta, E., Hassler, L., Wysocki, J., Chandar, V., Schwartz, R. E., Mirazimi, A., Montserrat, N., Bader, M. & Penninger, J. M., May 26 2022, In: Cell. 185, 11, p. 1837-1839 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Scopus citations -
A novel soluble ACE2 variant with prolonged duration of action neutralizes SARS-CoV-2 infection in human kidney organoids
Wysocki, J., Ye, M., Hassler, L., Gupta, A. K., Wang, Y., Nicoleascu, V., Randall, G., Wertheim, J. A. & Batlle, D., Apr 2021, In: Journal of the American Society of Nephrology. 32, 4, p. 795-803 9 p.Research output: Contribution to journal › Article › peer-review
Open Access43 Scopus citations -
An update on ACE2 amplification and its therapeutic potential
Marquez, A., Wysocki, J., Pandit, J. & Batlle, D., Jan 2021, In: Acta Physiologica. 231, 1, e13513.Research output: Contribution to journal › Review article › peer-review
21 Scopus citations